Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 50 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 117 | 7,183−0.3%/yr | −0.3%/yr | 8.00.9× | 12% | 8,190 in 2030+2.2%/yr |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 12 |
| 677+16%/yr |
| +16%/yr |
| 0.71.2× |
| 46% |
| 1,170 in 2030+9.5%/yr |
| Tumor ablation | 4 | 431−1.7%/yr | −1.7%/yr | 0.51.8× | 0% | 590 in 2030+5.3%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.